Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
163.60    2.00 (1.24%)
Bid:
164.20
Ask:
164.60
Spread: 0.40 (0.244%)
Market Cap: £398.70m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding

21 May 2021 14:05

RNS Number : 4807Z
Sabre Insurance Group PLC
21 May 2021
 

21 May 2021

 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

Awards under the Company's Long Term Incentive Plan

The Company announces that on 21 May 2021 the following directors and PDMRs of the Company were, subject to the rules of the Sabre 2017 Long Term Incentive Plan, each granted a conditional award (the 'LTIP Award') of ordinary shares of £0.001 in the Company as detailed below:

 

Name

Position

Number of shares subject to award

Geoff Carter

Chief Executive Officer

126,539

Anneka Kingan

Chief Risk and Officer & Company Secretary

47,638

Trevor Webb

Claims Director

78,790

Adam Westwood

Chief Financial Officer

59,548

Matt Wright

Chief Actuary

48,220

 

The awards will vest on the third anniversary of their grant, and are subject to an additional retention period of two years, commencing on the awards' vesting date.

 

The vesting of the awards will be subject to the following underpins:

· that the solvency coverage ratio of the Group (being the ratio of the Group's Solvency II net assets to its Solvency Capital Requirement, calculated before the final dividend is paid, expressed as a percentage) is maintained in excess of 140% for the three financial years up to 31 December 2023;

· that the Group has achieved a return on tangible equity (being the ratio of the Group's adjusted profit after tax to its average tangible equity, expressed as a percentage) in excess of 10% for each full reporting period which falls within the three financial years up to 31 December 2023;

· that there has been no material intervention by a regulatory authority either initiated during the three financial years up to 31 December 2023 or related to it, that results in a Group Member being required by the relevant authority to undertake actions or remedial measures; and

· overall Committee discretion.

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Geoff Carter

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

126,539

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

126,539

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Anneka Kingan

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Risk Officer and Company Secretary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

47,638

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

47,638

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Webb

2

 

Reason for the notification

 

a)

 

Position/status

 

Claims Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

78,790

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

78,790

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

 

 

 

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Adam Westwood

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

59,548

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

59,548

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Matt Wright

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Actuary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

48,220

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

48,220

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXFLFLFELBBBL
Date   Source Headline
22nd Apr 202110:00 amRNSDirector/PDMR Shareholding Replacement
22nd Apr 20219:51 amRNSDirector/PDMR Shareholding
14th Apr 20219:01 amRNSDirector/PDMR Shareholding
13th Apr 202111:12 amRNSDirector/PDMR Shareholding
12th Apr 20214:41 pmRNSNotice of AGM
7th Apr 20212:16 pmRNSDirector/PDMR Shareholding
30th Mar 20211:56 pmRNSDirector/PDMR Shareholding
26th Mar 20218:24 amRNSDirector/PDMR Shareholding
16th Mar 20217:03 amRNSFinal Results
12th Mar 20217:00 amRNSNotice of Results
11th Mar 202110:37 amRNSDirector/PDMR Shareholding
1st Mar 20213:56 pmRNSHolding(s) in Company
23rd Feb 202110:40 amRNSNotice of Results
11th Feb 202110:28 amRNSDirector/PDMR Shareholding
1st Feb 202110:02 amRNSHolding(s) in Company
12th Jan 202110:53 amRNSDirector/PDMR Shareholding
8th Jan 20219:44 amRNSHolding(s) in Company
11th Dec 20201:31 pmRNSDirector/PDMR Shareholding
3rd Dec 20207:56 amRNSHolding(s) in Company
3rd Dec 20207:00 amRNSBoard Appointment
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:37 pmRNSPrice Monitoring Extension
11th Nov 202012:07 pmRNSDirector/PDMR Shareholding
6th Nov 202011:39 amRNSHolding(s) in Company
6th Nov 202010:55 amRNSHolding(s) in Company
27th Oct 20203:47 pmRNSDirector/PDMR Shareholding
15th Oct 20207:00 amRNSDirector/PDMR Shareholding
13th Oct 20209:42 amRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSTrading Statement
11th Sep 202010:07 amRNSDirector/PDMR Shareholding
3rd Sep 20204:13 pmRNSDirector/PDMR Shareholding
1st Sep 20202:23 pmRNSDirector/PDMR Shareholding
28th Aug 202012:02 pmRNSPrice Monitoring Extension
27th Aug 202011:32 amRNSDirector/PDMR Shareholding
19th Aug 20207:00 amRNSDirectorate Change
12th Aug 20203:50 pmRNSHolding(s) in Company
11th Aug 20201:15 pmRNSDirector/PDMR Shareholding
10th Aug 20204:00 pmRNSHolding(s) in Company
6th Aug 202012:14 pmRNSDirector/PDMR Shareholding - Correction
6th Aug 202010:11 amRNSDirector/PDMR Shareholding
6th Aug 20209:32 amRNSDirector/PDMR Shareholding
3rd Aug 202012:54 pmRNSDirector/PDMR Shareholding
28th Jul 20207:02 amRNSBoard appointment
28th Jul 20207:00 amRNSHalf-year Report
14th Jul 20204:13 pmRNSHolding(s) in Company
13th Jul 202012:51 pmRNSDirector/PDMR Shareholding
30th Jun 20201:33 pmRNSDirector/PDMR Shareholding
11th Jun 20201:59 pmRNSDirector/PDMR Shareholding
10th Jun 20209:57 amRNSDirector/PDMR Shareholding - Correction
4th Jun 20209:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.